| Effect of Silver Nanoparticles Against the Formation of Biofilm by Pseudomonas aeruginosa an In silico Approach SS Vyshnava, DK Kanderi, SP Panjala, K Pandian, RR Bontha, ... Applied biochemistry and biotechnology 180, 426-437, 2016 | 34 | 2016 |
| Advances in the development of phage-based probes for detection of bio-species K Paramasivam, Y Shen, J Yuan, I Waheed, C Mao, X Zhou Biosensors 12 (1), 30, 2022 | 25 | 2022 |
| Gram scale synthesis of QD450 core–shell quantum dots for cellular imaging and sorting SS Vyshnava, G Pandluru, DK Kanderi, SP Panjala, S Banapuram, ... Applied Nanoscience 10, 1257-1268, 2020 | 13 | 2020 |
| Quantum dots based in-vitro co-culture cancer model for identification of rare cancer cell heterogeneity SS Vyshnava, G Pandluru, KD Kumar, SP Panjala, S Banapuram, ... Scientific Reports 12 (1), 5868, 2022 | 12 | 2022 |
| Genetic diversity and relationship of Indian Muscovy duck populations P Kameshpandian, S Thomas, M Nagarajan Mitochondrial DNA Part A 29 (2), 165-169, 2018 | 10 | 2018 |
| Biocompatible Ni‐doped CdSe/ZnS semiconductor nanocrystals for cellular imaging and sorting SS Vyshnava, G Pandluru, KD Kumar, SP Panjala, K Paramasivam, ... Luminescence 37 (3), 490-499, 2022 | 6 | 2022 |
| A Computational Approach for Protein-Protein Interactions of Bacterial Surface Layer Protein with Human Erb3 and αIIB-β3 Receptors Biointerface Research in Applied Chemistry 12 (1), 420-430, 2021 | 4* | 2021 |
| Genetic diversity of Muscovy ducks revealed by mtDNA d-loop K Paramasivam, SS Vyshnava, DK Kanderi, C Pertoldi IOSR J. Biotechnol. Biochem 3, 11-18, 2017 | 4 | 2017 |
| A computational approach on the activity of hesperidin as antagonist for proteins of SARS-CoV-2 SS Vyshnava, DK Kanderi, SP Panjala, K Paramasivam, G Pandluru, ... | 3 | 2020 |
| Anti-cancer activity of crude Slrp protein conjugated mesoporous silica nanoparticles in HeLa Cell Lines: An in vitro approach SP Panjala, SS Vyshnava, S Banapuram, V Vasikarla, P Kameshpandian, ... Journal of Applied and Natural Science 16 (1), 364-377, 2024 | | 2024 |
